Precision BioSciences, Inc. (DTIL) vs Organogenesis Holdings Inc. (ORGO)

A side-by-side comparison of Precision BioSciences, Inc. and Organogenesis Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DTIL vs ORGO

growth of $100 · dividends reinvested · last 8y
DTIL -98.8% (-42.4%/yr)ORGO -84.2% (-20.6%/yr)ORGO compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$1$16
DTIL ORGO

DTIL vs ORGO: by the numbers

  • •DTIL is the larger company ($173M vs $170M market cap).
  • •Both run net losses; ORGO's is the smaller (-19.76% vs -117.04% net margin).
  • •DTIL grew revenue faster over the past five years (7.13% vs 1.05% CAGR).

Metrics side by side

Valuation

MetricDTILORGO
P/S ratio3.840.37
P/B ratio3.821.15
EV / EBITDAN/A214.76
FCF yieldN/A12.22%

Profitability

MetricDTILORGO
Gross margin100.00%67.59%
Operating margin-152.19%9.92%
Net margin-117.04%-19.76%
ROE-116.42%-31.32%
ROIC-30.23%-8.34%

Growth (annualized)

MetricDTILORGO
Revenue CAGR (5Y)7.13%1.05%
FCF CAGR (5Y)N/A-5.54%
Total return CAGR (5Y)-54.84%-37.41%

Frequently asked

Which has grown faster, DTIL or ORGO?
Over the past five years, DTIL grew revenue faster — DTIL at a 7.13% CAGR versus ORGO at 1.05%.
How have DTIL and ORGO total returns compared?
Over the past 5 years, DTIL delivered -54.84% and ORGO delivered -37.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.